XCRP — Xcorporeal Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Xcorporeal, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2004 December 31st	2005 December 31st	R2006 December 31st	2007 December 31st	2008 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB	10KSB	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4.23	-0.672	-4.38	-17.1	-23
Depreciation
Non-Cash Items	-0.046	0.161	2.43	6.74	5.61
Unusual Items
Other Non-Cash Items
Changes in Working Capital	4.05	0.468	2.02	-0.462	4.54
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-0.226	-0.043	0.071	-10.8	-12.7
Capital Expenditures	—	—	-0.003	-0.296	-0.175
Purchase of Fixed Assets
Other Investing Cash Flow Items	0.025	0	0	-16.5	13.2
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	0.025	0	-0.003	-16.8	13
Financing Cash Flow Items	0.2	0	0.03	0	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.205	0.039	27.4	0.199	0
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.004	-0.004	27.4	-27.3	0.301